SE389671B - Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan - Google Patents

Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan

Info

Publication number
SE389671B
SE389671B SE7310384A SE7310384A SE389671B SE 389671 B SE389671 B SE 389671B SE 7310384 A SE7310384 A SE 7310384A SE 7310384 A SE7310384 A SE 7310384A SE 389671 B SE389671 B SE 389671B
Authority
SE
Sweden
Prior art keywords
aroyl
spec
therapeutic
procedure
preparation
Prior art date
Application number
SE7310384A
Other languages
English (en)
Swedish (sv)
Inventor
J R Carson
Original Assignee
Mcneilab Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mcneilab Inc filed Critical Mcneilab Inc
Publication of SE389671B publication Critical patent/SE389671B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/32Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/33Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D207/337Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D207/00Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/30Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D207/34Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SE7310384A 1972-08-03 1973-07-26 Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan SE389671B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00277845A US3846447A (en) 1972-08-03 1972-08-03 Preparation of 5-aroyl-pyrroles and intermediates therefor

Publications (1)

Publication Number Publication Date
SE389671B true SE389671B (sv) 1976-11-15

Family

ID=23062597

Family Applications (2)

Application Number Title Priority Date Filing Date
SE7310384A SE389671B (sv) 1972-08-03 1973-07-26 Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan
SE7602534A SE7602534L (sv) 1972-08-03 1976-02-26 5-klorokarbonylpyrroler

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE7602534A SE7602534L (sv) 1972-08-03 1976-02-26 5-klorokarbonylpyrroler

Country Status (9)

Country Link
US (1) US3846447A (en, 2012)
JP (1) JPS4955659A (en, 2012)
AT (1) AT325602B (en, 2012)
CA (1) CA1002528A (en, 2012)
DE (1) DE2339140A1 (en, 2012)
FR (1) FR2239246B1 (en, 2012)
GB (1) GB1428272A (en, 2012)
NL (1) NL7310359A (en, 2012)
SE (2) SE389671B (en, 2012)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4140696A (en) * 1973-08-22 1979-02-20 Gruppo Lepetit S.P.A. Aminopyrrole derivatives
US4187230A (en) * 1975-05-27 1980-02-05 Ethyl Corporation Preparation of 5-aroyl-pyrrole compounds
US3998844A (en) * 1975-06-02 1976-12-27 Mcneil Laboratories, Incorporated Uncatalyzed aroylation of 1-alkylpyrrole-2-acetic acid derivatives
US4048191A (en) * 1975-06-27 1977-09-13 Mcneil Laboratories, Incorporated Halo-substituted 1-loweralkyl-5-aroylpyrrole-2-acetic acid compounds
US4125537A (en) * 1977-02-07 1978-11-14 Mcneil Laboratories, Incorporated Preparation of pyrrole-2-acetates
US4097579A (en) * 1977-03-31 1978-06-27 Syntex (U.S.A.) Inc. 5-(2-Pyrroyl)-1,2-dihydro-3H-pyrrolo 1,2-a!pyrrole-1-carboxylic acid derivatives and process for the production thereof
US4200645A (en) * 1977-05-10 1980-04-29 Beecham Group Limited Pyrrole derivatives
US4119639A (en) * 1977-06-27 1978-10-10 Mcneil Laboratories, Incorporated Preparation of 5-aroylpyrrole-2-acetic acid derivatives
JPS5481264A (en) * 1977-12-08 1979-06-28 Sagami Chem Res Center Preparation of 1-methyl-5-aroylpryrrole-2-acetic acid
DE2862262D1 (en) * 1978-10-27 1983-07-07 Mcneilab Inc Process of reducing a loweralkyl 1-loweralkyl-pyrrole-2-glyoxylate to a loweralkyl 1-loweralkyl-pyrrole-2-acetate
US4246176A (en) * 1979-07-05 1981-01-20 Ethyl Corporation Synthesis of 5-aroyl-1-hydrocarbylpyrrole-2-acetic acid
WO2009072139A1 (en) * 2007-12-07 2009-06-11 Matrix Laboratories Limited Process for producing 2-[1-methyl-5-(4-methylbenzoyl)- pyrrol-2- yl]acetic acid or salt thereof
CN103435527B (zh) * 2013-09-03 2015-09-23 张家港市信谊化工有限公司 一种非甾体抗炎药托美汀的制备方法

Also Published As

Publication number Publication date
AT325602B (de) 1975-10-27
JPS4955659A (en, 2012) 1974-05-30
SE7602534L (sv) 1976-02-26
FR2239246A1 (en, 2012) 1975-02-28
ATA678373A (de) 1975-01-15
FR2239246B1 (en, 2012) 1977-04-15
NL7310359A (en, 2012) 1974-02-05
DE2339140A1 (de) 1974-02-14
CA1002528A (en) 1976-12-28
US3846447A (en) 1974-11-05
GB1428272A (en) 1976-03-17

Similar Documents

Publication Publication Date Title
SE417205B (sv) Forfarande for framstellning av foreningar med autibiotisk verkan
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
SE405599B (sv) Forfarande for framstellning av pyridazinoner med terapeutisk verkan
SE385885B (sv) Foerfarande foer framstaellning av 4-amino-6-arylpyrimidinderivat
SE395149B (sv) Forfarande for framstellning av dibenso-tiepinylpiperazinderivat
SE389671B (sv) Fforfarande for framstellning av 5-aroyl-pyrrolderivat med terapeutisk spec antiinflammatorisk verkan
SE401676B (sv) Forfarande for framstellning av dibensofuranderivat
SE403911B (sv) Forfarande for framstellning av aroylsubstituerade fenylettiksyraderivat med anti-inflammatorisk verkan
SE405477B (sv) Forfarande for framstellning av tetrazolyl-kinaldinsyraderivat med farmakologisk verkan
SE380522B (sv) Forfarande for framstellning av (1- (p-klorbensoyl)-5-metoxi-2-metyl-3-indol) - acetoxiettiksyra med antiflogistisk verkan
SE395892B (sv) Forfarande for framstellning av piperidyl-bensimidazoliner med terapeutisk verkan
SE401673B (sv) Forfarande for framstellning av 2-substituerade 5-sulfamyl-bensoesyror med plasmalipidsenkande verkan
SE411671B (sv) Forfarande for framstellning av tripeptidderivat med terapeutisk verkan
SE380273B (sv) Forfarande for framstellning av tiopyrimidinderivat
SE397827B (sv) Forfarande for framstellning av 1-aminometyl-2,2-difenylcyklopropankarboxamidderivat med terapeutisk verkan
SE392722B (sv) Forfarande for framstellning av oxazolidinderivat med terapeutisk verkan
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
SE7514308L (sv) Forfarande for framstellning av tyrosinderivat med terapeutisk verkan
SE393801B (sv) Forfarande for framstellning av tiokarbaminsyraderivat med antifungistatisk lekemedelsverken
SE430331B (sv) Forfarande for framstellning av substituerade fenylalkylaminoalkylbensenderivat med terapeutisk verkan
SE380517B (sv) Forfarande for framstellning av fluoren-2-ettiksyraderivat med antiinflammatorisk verkan
SE389108B (sv) Forfarande for framstellning av cyklopropylfenylpyrrolidinderivat med farmakologisk verkan
SE385696B (sv) Nytt forfarande for framstellning av n-(1-etyl-alfa-pyrrolidylmetyl)-2-metoxi-5-sulfamidobensamid med terapeutiska egenskaper
SE394429B (sv) Forfarande for framstellning av aminopyrrolderivat med terapeutisk verkan
SE7608115L (sv) Forfarande for framstellning av kinoxalinderivat med terapeutisk verkan